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DGLA = dihomo-γ-linolenic acid; EPA = eicosapentaenoic acid; GLA = γ-linolenic acid; HLA = human leukocyte antigen.
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Septic shock is the most common cause of death in intensive
care units. In the USA alone, more than 100,000 deaths
occur as a result of septicemia and septic shock per year (for
review [1]).
In a prospective, randomized, controlled study involving
adults admitted to surgical intensive care units and receiving
mechanical ventilation [2], intensive insulin therapy
substantially reduced mortality and morbidity. Intensive insulin
treatment reduced the number of deaths from multiple organ
failure with sepsis. Markers of inflammation were found to be
less frequently abnormal in the intensive insulin treatment
group than in the conventional treatment group, although the
nature of the inflammatory markers measured was not given.
While commenting on this interesting study, Groeneveld and
coworkers [3] outlined the possible mechanisms that could
be responsible for this beneficial action of insulin in the
critically ill. I was the first to suggest that the beneficial action
of insulin (administered in the form of a
glucose–insulin–potassium regimen) in patients with acute
myocardial infarction, especially those who are poor
candidates for thrombolytic therapy and in whom the risk of
bleeding is high, can be ascribed to its ability to suppress the
production and harmful actions of tumor necrosis factor-α,
macrophage migration inhibitory factor, and free radicals
[1,4,5].
Recent studies have provided further evidence for the anti-
inflammatory actions of insulin. For instance, insulin infusion
decreased concentrations of intranuclear NF-κB in
mononuclear cells, increased levels of its inhibitor, and
decreased the generation of reactive oxygen species and
levels of p47 (the key protein of nicotinamide dinucleotide
phosphate oxidase in obese persons) [6,7]. A significant
decrease in the concentrations of plasma soluble intercellular
adhesion molecule-1, monocyte chemoattractant protein-1,
and plasminogen activator inhibitor-1 was noted in those
obese persons after insulin administration. On the other
hand, high glucose induced acute inflammatory events in
rats, as evidenced by increased leukocyte rolling, leukocyte
adherence, leukocyte transmigration through mesenteric
venules associated with attenuation of endothelial nitric oxide
release, and increased expression of P-selectin on
endothelial surfaces [7,8]. Local application of insulin
attenuated these inflammatory actions of glucose. This anti-
inflammatory action of insulin may explain why insulin is more
beneficial during infections and after surgery than are oral
antidiabetic drugs for type 2 diabetes mellitus.
These actions of insulin and glucose on various parameters
associated with inflammation are interesting in light of the
relationship between human leukocyte antigen (HLA)-DR and
CD11b expression, free radical generation, and development
and recovery from postoperative or post-trauma sepsis
[1,9,10]. In patients with an uneventful recovery from severe
trauma or surgery, the level of monocyte HLA-DR expression
fell within hours of trauma or surgery, but returned to normal
within a week [9,10]. In those who developed infection but
recovered, 3 weeks were required for HLA-DR expression to
return to normal. Finally, in those who developed infection
and sepsis and who died as a result, HLA-DR expression fell
and never returned to normal. Similarly, after uncomplicated
elective major abdominal surgery, expression of
CD11b/CD18 (which is necessary for adhesion of
neutrophils to endothelium) was unchanged throughout the
postoperative period [9,11]; in patients who developed
postoperative sepsis, the expression of CD11b was
significantly elevated within 24 hours of surgery. Production
of hydrogen peroxide by neutrophils followed a pattern similar
to that of CD11b expression in these two groups of patients.
Even production of hypochlorous acid, a marker of neutrophil
activation, was decreased in patients who had
uncomplicated abdominal surgery as compared with those
who developed sepsis 7–10 days later, in whom its
production was augmented to supranormal levels on
postoperative day 1 [12]. It is interesting to note that these
changes in HLA-DR and CD11b expression, hydrogen
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peroxide, and hypochlorous acid production were noted even
when there was no evidence of infection.
Insulin stimulates the activity of the enzymes δ-6-desaturase
and δ-5-desaturase; these enzymes are essential in the
formation of γ-linolenic acid (GLA) and dihomo-γ-linolenic
acid (DGLA) from dietary linoleic acid, and of
eicosapentaenoic acid (EPA) and docosahexaenoic acid
from α-linolenic acid [13]. DGLA and EPA are precursors of
prostaglandin E1 and prostaglandin I2, respectively, and are
potent platelet antiaggregators and vasodilators.
Furthermore, GLA, EPA, DHA, and prostaglandin E1
suppress the synthesis and production of tumour necrosis
factor-α and interleukin-2 by human T cells (for review
[1,5,13]). This could be yet another mechanism by which
insulin functions as an endogenous anti-inflammatory
molecule. Furthermore, diets that are rich in EPA and DHA,
and continuous tube feeding or intravenous infusion of these
fatty acids improved survival of experimental animals
challenged with endotoxin (for review [1]). Previously, my
colleagues and I showed that patients with septicemia have
low concentrations of GLA, DGLA, arachidonic acid,
α-linolenic acid, and EPA in their plasma [5,14].
It is interesting to know that the variation in neutrophil
activation and HLA-DR expression between different groups
of patients was noted not preoperatively but only after surgery
or trauma, which is somewhat similar to the development of
insulin resistance in patients only when they are ill but not
before illness. This suggests that there are some very clear
biologic variations in the response of different individuals to
injury, surgery, infection, or sepsis that determines their ability
or inability to recover from the onslaught of the initial event.
The variations in neutrophil activation, HLA-DR expression,
concentrations of plasma polyunsaturated fatty acids, and/or
insulin resistance observed could account for some of this
biologic variation. Because insulin and glucose influence
neutrophil function, free radical generation, cytokine
generation and their action, and nitric oxide production, and
modulate essential fatty acid metabolism, it may be worthwhile
to measure some of these parameters in critically ill patients.
Such an approach may aid in implementing appropriate
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